Global Bone Cement & Glue Market by Type, by Application, by End User, Regional Insights and Forecast 2034
Overview
The Bone Cement & Glue Market size was valued at USD 1.56 Billion in 2025 and the total Bone Cement & Glue revenue is expected to grow at a CAGR of 6.1% from 2026 to 2034, reaching USD 2.66 Billion by 2034.
Global Bone Cement & Glue Market Overview
The global Bone Cement & Glue Market comprises biomaterials and medical adhesives used to fix orthopedic implants, stabilize bone structures, fill bone defects, and support bone repair during surgical procedures. Bone cement, particularly polymethyl methacrylate (PMMA), is widely used in joint replacement surgeries, vertebroplasty, and kyphoplasty, while bone glues and bioadhesives support bone bonding, fracture fixation, and tissue repair. The market includes synthetic and bio-based bone adhesives designed to improve implant stability, surgical outcomes, and patient recovery.
The global Bone Cement & Glue Market is expanding due to the increasing prevalence of osteoporosis, osteoarthritis, bone fractures, and other musculoskeletal disorders, alongside the rising number of hip and knee replacement surgeries. The growing geriatric population and increasing demand for minimally invasive orthopedic procedures support the adoption of bone cement and advanced bone adhesives. Technological advancements in bioresorbable adhesives, biocompatible materials, and improved cement formulations are further enhancing product performance and clinical applications.
Hospitals, ambulatory surgical centers, and orthopedic clinics represent key end users, while orthopedic surgery remains a major application area. Manufacturers are focusing on developing advanced bone fixation materials that offer improved bonding strength, biocompatibility, and reduced surgical complications. However, stringent regulatory requirements, risks associated with bone cement implantation, and the high cost of advanced biomaterials may restrain market growth.
Global Bone Cement & Glue Market Highlights:
1. Market Growth: Reaches USD 1.56 billion in 2025 and USD 2.66 billion by 2034, at a 6.1% CAGR.
2. Rising Orthopedic Surgeries: Increasing joint replacements and bone fractures drive market demand.
3. PMMA Cement Dominance: PMMA bone cement remains essential for orthopedic implant fixation.
4. Advanced Biomaterials: Regenerative bone adhesives and bioresorbable materials create new growth opportunities.
5. Competitive Landscape: Stryker, Zimmer Biomet, and Heraeus Medical strengthen innovation in orthopedic bone cement and fixation solutions.
Bone Cement & Glue Market Growth Outlook
To know about the Research Methodology :- Request Free Sample Report
Instead, it fills in the space where a diseased vertebra used to be. These are used to repair and tie together fractured or broken bones. The free space between the artificial joints and the bone is clogged and closed by these devices. These devices come in powder or liquid form and are used to speed up bone healing and repair.
Bone Cement & Glue Market Dynamics:
Global Bone Cement & Glue Market Driver:
Rising Orthopedic Surgeries and Demand for Advanced Bone Fixation: The global Bone Cement & Glue Market benefits from the increasing prevalence of osteoarthritis, osteoporosis, traumatic fractures, and age-related musculoskeletal disorders. The growing number of hip and knee replacement procedures increases demand for polymethyl methacrylate (PMMA) bone cement, antibiotic-loaded bone cement, and advanced orthopedic fixation materials. According to the World Health Organization, the global population aged 60 years and older reaches an estimated 2.1 billion by 2050, strengthening long-term demand for joint reconstruction and fracture management. At the same time, innovations in minimally invasive orthopedic surgery and cemented implant fixation support demand for reliable bone cement and emerging surgical bioadhesives. Recent advances in injectable biomaterials, bioactive bone substitutes, and infection-resistant cement formulations further strengthen the market outlook by improving surgical precision, implant stability, and patient recovery.
Global Bone Cement & Glue Market Restraint:
Stringent Regulatory Requirements and High Clinical Development Costs: The Bone Cement & Glue Market faces restraints from stringent medical device regulations, high product development costs, and the need for extensive clinical validation. Manufacturers must demonstrate biocompatibility, mechanical strength, sterilization compatibility, long-term stability, and safety before introducing new bone adhesives and orthopedic cement formulations. Novel bone glues face additional challenges because their performance must be validated under wet physiological conditions and repetitive mechanical loading. Regulatory frameworks such as the European Union Medical Device Regulation (EU MDR) and the US Food and Drug Administration's device approval pathways increase compliance requirements and commercialization timelines. In addition, reimbursement limitations, price pressure from established orthopedic products, and the cost of clinical trials restrict adoption, particularly for emerging biomimetic adhesives and regenerative bone fixation technologies.
Global Bone Cement & Glue Market Opportunity:
Expansion of Biomimetic Bone Adhesives and Regenerative Orthopedic Materials: The global Bone Cement & Glue Market presents significant opportunities through the development of biomimetic bone adhesives, bioresorbable bone cement, injectable bone void fillers, and regenerative orthopedic biomaterials. These technologies target complex fractures, comminuted fractures, craniofacial reconstruction, dental bone regeneration, and fixation in patients with poor bone quality. In September 2026, Uppsala University reports that OsStic bone glue enters human clinical evaluation in England, targeting fractures near joints. The calcium-phosphate and phosphoserine-based material is designed to bond bone fragments and gradually break down as new bone forms. This development creates opportunities for manufacturers to commercialize next-generation bone adhesives that combine mechanical fixation with bone regeneration.
Global Bone Cement & Glue Market Challenge:
Limited Clinical Evidence and Mechanical Performance under Wet Conditions: The Bone Cement & Glue Market faces technical challenges in developing bone adhesives that maintain strong adhesion in blood, moisture, and physiological fluids while withstanding repetitive loading and natural bone movement. Manufacturers must balance rapid setting time, high adhesive strength, biocompatibility, controlled degradation, and osteointegration without interfering with bone healing. Conventional PMMA bone cement has established clinical applications, whereas emerging bioadhesives require further clinical validation across different fracture types and anatomical locations. A May 2025 review of antibiotic-loaded bone cement in primary hip and knee arthroplasty also highlights limitations in high-level clinical evidence, demonstrating the importance of evidence-based product selection and infection-prevention protocols.
Global Bone Cement & Glue Market Trend:
Development of Antibiotic-Loaded and Bioactive Bone Cement: The Bone Cement & Glue Market increasingly focuses on antibiotic-loaded bone cement, bioactive calcium phosphate formulations, injectable bone adhesives, and materials that support bone regeneration. Antibiotic-loaded formulations deliver antimicrobial agents locally and remain important in orthopedic infection management, particularly in revision arthroplasty and selected high-risk procedures. In October 2025, Heraeus Medical expands its regenerative orthopedics portfolio through the integration of INNOTERE and introduces the heracure product line, featuring calcium-phosphate bone regeneration solutions and 3D-printed biomaterials. These developments demonstrate a broader industry shift toward specialized orthopedic biomaterials that combine fixation, infection management, and regenerative capabilities.
Another emerging trend involves minimally invasive bone repair and personalized orthopedic treatment. Injectable bone cement, bioresponsive hydrogels, and biomimetic adhesives offer potential for treating complex fractures through targeted delivery and reduced reliance on extensive hardware. Research published in Advanced Science in July 2025 investigates a dual-biomimetic bone adhesive with osteoimmunomodulatory properties for reconstructing comminuted fractures. Such research strengthens innovation in regenerative bone adhesives, although clinical effectiveness and commercial adoption depend on further validation.
Global Bone Cement & Glue Market Segment Analysis
By Type, The global Bone Cement & Glue Market is segmented into bone cement and bone glue, with bone cement representing an established product category in orthopedic implant fixation and spinal procedures. Polymethyl methacrylate (PMMA) bone cement holds a significant position due to its extensive use in total knee arthroplasty, total hip arthroplasty, and other joint replacement surgeries. Calcium phosphate cement supports bone defect filling and bone regeneration, while glass polyalkenoate cement finds applications primarily in dental procedures and selected specialized treatments. The market also includes antibiotic-loaded bone cement, which supports local antibiotic delivery in appropriate orthopedic procedures, and non-antibiotic-loaded bone cement for conventional implant fixation. Bone glue comprises natural and synthetic bone adhesives designed to improve bone bonding, fracture stabilization, and tissue repair. Manufacturers such as Heraeus Medical, Stryker, Zimmer Biomet, and DePuy Synthes contribute to the established orthopedic bone cement market, while research into biomimetic and bioresorbable adhesives supports emerging opportunities in advanced bone fixation technologies.
By Application, the Bone Cement & Glue Market covers total knee arthroplasty, total hip arthroplasty, total shoulder arthroplasty, kyphoplasty, vertebroplasty, dental applications, and other orthopedic procedures. Total knee and total hip arthroplasty represent important application segments because bone cement supports the fixation of artificial joints in patients with osteoarthritis, osteoporosis, and other degenerative joint conditions. Kyphoplasty and vertebroplasty utilize injectable bone cement in selected cases of vertebral compression fractures, particularly among patients with weakened bones. Dental applications include eligible dental cement and bone adhesive products used in oral surgery, implant-related procedures, and bone reconstruction. Increasing orthopedic surgery volumes, the aging population, rising fracture incidence, and advances in minimally invasive surgical techniques support demand across these applications. Continued development of bioactive bone cement, injectable biomaterials, and advanced bone adhesives further expands the potential applications of bone fixation materials.
By End User, the global Bone Cement & Glue Market is segmented into hospitals, ambulatory surgery centers, and clinics or physician offices. Hospitals represent a major end-user category because they provide specialized orthopedic surgery, joint replacement, trauma management, spinal interventions, and complex reconstructive procedures. Their access to advanced surgical infrastructure, orthopedic specialists, and implant procurement systems supports demand for PMMA bone cement, antibiotic-loaded bone cement, and other orthopedic biomaterials. Ambulatory surgery centers contribute to market demand through eligible outpatient orthopedic procedures and selected same-day surgical treatments. Clinics and physician offices support specialized outpatient care, including eligible dental and related bone repair procedures. The growing adoption of advanced orthopedic technologies, increasing access to surgical care, and rising demand for efficient patient recovery pathways support the expansion of bone cement and bone glue products across healthcare facilities.
Bone Cement & Glue Market Regional Insights:
| Region | Competitive position | Primary growth drivers | Key market challenges |
| North America | Leading established market | Orthopedic surgery volumes, advanced hospitals, established manufacturers | Pricing pressure, cementless implants, regulatory costs |
| Europe | Major established market | Aging population, specialist manufacturers, joint reconstruction | MDR compliance, procurement costs |
| Asia Pacific | High-growth opportunity | Expanding hospitals, aging population, improving access to orthopedic surgery | Price sensitivity, regulatory variation, uneven access |
| Latin America | Developing market | Joint replacement demand, trauma care, healthcare modernization | Economic volatility, import dependence |
| Middle East & Africa | Developing market | Hospital investment, specialist care expansion, orthopedic infrastructure | Distribution limitations, reimbursement and access barriers |
North America: The North America Bone Cement & Glue Market holds a leading position, driven by rising joint replacement surgeries, an aging population, advanced orthopedic healthcare infrastructure, and strong demand for PMMA bone cement and antibiotic-loaded bone cement. The presence of key players such as Stryker, Zimmer Biomet, and Johnson & Johnson MedTech strengthens regional competition. Increasing adoption of spinal augmentation and advanced bone fixation technologies supports market growth through 2034. For example, Heraeus Medical receives European MDR certification for its COPAL G+V dual-antibiotic bone cement in March 2025, illustrating the importance of regulatory compliance and product differentiation in the international bone cement industry. Although this certification concerns the European market, it also demonstrates the regulatory standards relevant to manufacturers supplying North American and other regulated markets.
Europe: Europe represents the second-largest regional market in the cited 2025 combined-market estimate, supported by established orthopedic care systems, a large aging population, advanced joint reconstruction services, and a strong presence of bone cement manufacturers. The Europe Bone Cement & Glue Market benefits from an established orthopedic industry, increasing prevalence of osteoporosis, and growing demand for hip and knee arthroplasty. Germany, France, the United Kingdom, and Italy represent important markets, supported by manufacturers such as Heraeus Medical, TEKNIMED, Tecres, and OSARTIS. Regulatory compliance, product innovation, and advances in antibiotic-loaded bone cement and orthopedic biomaterials shape the regional market outlook.
Asia Pacific: The Asia Pacific Bone Cement & Glue Market presents strong growth opportunities due to expanding healthcare infrastructure, rising orthopedic surgery volumes, and increasing demand for joint replacement and fracture management. China, India, Japan, and South Korea contribute through growing hospital capacity, an aging population, and improving access to orthopedic treatments. Rising demand for cost-effective bone cement, injectable biomaterials, and advanced bone fixation products supports regional market expansion.
South America: The South America Bone Cement & Glue Market expands with increasing demand for orthopedic surgery, joint replacement procedures, fracture stabilization, and spinal augmentation. Brazil and Argentina represent important markets, while Colombia and Chile offer additional opportunities through healthcare infrastructure development and improving access to specialized orthopedic care. Demand for PMMA bone cement, antibiotic-loaded bone cement, and orthopedic implant fixation materials benefits from the growing prevalence of osteoarthritis and osteoporosis. However, economic fluctuations, import dependence, reimbursement limitations, and uneven healthcare access influence market penetration.
Middle East & Africa: The Middle East & Africa Bone Cement & Glue Market benefits from healthcare infrastructure investments, expanding specialist hospitals, and increasing demand for orthopedic and trauma care. Saudi Arabia, the United Arab Emirates, and South Africa represent important markets for bone cement, orthopedic biomaterials, and joint reconstruction products. Growing healthcare modernization and improved access to surgical procedures create opportunities, although import dependence, distribution challenges, and affordability constraints influence market growth.
The objective of the report is to present a comprehensive analysis of the global Bone Cement & Glue market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the global Bone Cement & Glue market dynamics, structure by analyzing the market segments and project the global Bone Cement & Glue market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Bone Cement & Glue market make the report investor’s guide.
Global Bone Cement & Glue Market Competitive Landscape:
The global Bone Cement & Glue Market features established orthopedic biomaterial manufacturers, including Heraeus Medical, Stryker, Zimmer Biomet, DePuy Synthes, Smith+Nephew, TEKNIMED, and Tecres. These companies compete through bone cement formulations, antibiotic-loaded products, implant fixation solutions, delivery systems, and specialized orthopedic biomaterials. Market competition increasingly emphasizes product quality, biocompatibility, mechanical strength, infection management, and compatibility with surgical procedures. Meanwhile, emerging research into biomimetic bone adhesives, bioresorbable polymers, and regenerative bone fixation materials creates opportunities for innovation beyond conventional PMMA bone cement. The development of advanced orthopedic biomaterials and expanding applications in joint replacement, spinal surgery, fracture stabilization, and bone reconstruction continue to shape the competitive outlook through 2034.
| No. | Company | Primary region | Competitive category | Market relevance and product focus | Indicative competitive position |
| 1 | Stryker | North America | Global leader | SIMPLEX bone cement and spinal cement products | High — established |
| 2 | Zimmer Biomet | North America | Global leader | Orthopedic bone cement, antibiotic-loaded formulations and implant fixation | High — established |
| 3 | Johnson & Johnson / DePuy Synthes | North America / Europe | Global leader | Orthopedic bone cement and joint reconstruction products | High — established |
| 4 | Heraeus Medical | Europe | Global specialist | PALACOS and COPAL bone cement portfolios | High — established |
| 5 | Smith+Nephew | Europe | Global orthopedic player | Orthopedic implants and associated cement products | High — established |
| 6 | Enovis / DJO Global | North America | Global orthopedic player | Orthopedic technologies and bone cement market participation | Medium — portfolio dependent |
| 7 | Exactech | North America | Orthopedic implant player | Joint replacement systems and associated fixation requirements | Medium — verify product scope |
Global Bone Cement & Glue Market Recent Development:
| Exact date | Company / Organization | Recent development | Market impact |
| January 28, 2026 | RevBio | The US FDA greenlights RevBio’s pivotal clinical trial for TETRANITE bone glue for cranial flap fixation. | Advances clinical development of regenerative bone adhesives for cranial reconstruction. |
| February 1, 2026 | Heraeus Medical | Officially launches the heracure one and heracure 3D product families, featuring resorbable calcium phosphate biomaterials for bone regeneration. | Expands the regenerative orthopedics portfolio with injectable and 3D-printed bone substitute materials. |
| May 27, 2026 | Biomimetic Innovations / Dublin City University | Reports that OsStic synthetic injectable bone adhesive receives UK MHRA approval for a first-in-human clinical study. The approval announcement itself occurs earlier in May. | Supports clinical evaluation of next-generation bone adhesives for complex fractures. |
| May 22, 2026 | Zimmer Biomet / OSARTIS | Australia's TGA registers Hi-Fatigue G medicated bone cement. | Supports product registration and market access for orthopedic bone cement. |
| August 5, 2026 | Heraeus Medical / NHS Supply Chain | NHS Supply Chain publishes an update on the phased reintroduction of Heraeus bone cement products following a manufacturing disruption. | Highlights the importance of reliable supply chains and alternative bone cement products. |
| September 2, 2026 | RevBio | Publishes findings from its TETRANITE bone regeneration study conducted aboard the International Space Station. | Provides research evidence supporting further investigation of regenerative bone adhesives. |
Global Bone Cement & Glue Market Scope: Inquire before buying
| Global Bone Cement & Glue Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 1.56 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 6.1% | Market Size in 2034: | USD 2.66 Bn. |
| Segments Covered: | by Type | Bone Cement PMMA Cement Calcium Phosphate Cement Glass Polyalkenoate Cement Non-Antibiotic Loaded Bone Cement Antibiotic Loaded Bone Cement Bone Glue Natural Bone Glue Synthetic Bone Glue |
|
| by Application | Dental Applications Arthroplasty Total Knee Arthroplasty Total Hip Arthroplasty Total Shoulder Arthroplasty Kyphoplasty Vertebroplasty |
||
| by End User | Hospitals Ambulatory Surgery Centers Clinics/Physician Offices |
||
Bone Cement & Glue Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Bone Cement & Glue Market,Key Players are:
1. Smith & Nephew
2. Zimmer Biomet
3. Cardinal Health
4. DJO Global
5. Heraeus Medical
6. Arthrex
7. CryoLife
8. DePuy Synthes
9. TEKNIMED
10. Exactech
11. Stryker
12. Triumph
13. 3M
14. BSN Medical
15. Medtronic
16. Globus Medical
17. Johnson & Johnson Services Inc.
18. aap Implantate AG
19. Tecres S.p.A.
20. Orthofix Medical Inc.
21. OSARTIS GmbH
22. Synimed
23. G21 S.r.l.
24. BAOT Biomaterials
25. Elite-Medical (Sun-Summit)
26. Shanghai Puwei Medical
27. Subiton Laboratorios
28. Enovis Corporation
29. Medacta International
30. MicroPort Orthopedics
31. LimaCorporate
32. Alphatec Holdings
33. KLS Martin
34. Spineart
35. Mathys
36. Merit Medical Systems
37. Cook Medical
38. B. Braun
39. Seikagaku Corporation
40. RevBio
41. Biomimetic Innovations
42. Coligne AG
43. IZI Medical Products
44. Slaney Healthcare
45. Evolutis
Frequently Asked questions
1. What is the market size of the Global Bone Cement & Glue Market in 2025?
Ans. The market size Global market in 2025 was USD 1.56 Billion.
2. What are the different segments of the Global Bone Cement & Glue Market ?
Ans. The Global market is divided into Type, Application and End User.
3. What is the study period of this market?
Ans. The Global market will be studied from 2020 to 2034.
4. Which region is expected to hold the highest Global Bone Cement & Glue Market share?
Ans. The North America dominates the market share in the market.
5. What is scope of the Global Bone Cement & Glue Market report?
Ans: Global Bone Cement & Glue Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
